patpitchaya/iStock via Getty Images JNJ stock: buy rating reiterated It was about three months ago that I last analyzed Johnson & Johnson (NYSE:JNJ) stock. As the following screenshot shows, my last article was titled "Johnson & Johnson: Market Will Regret The Overreaction" and rated the stock as a buy. The article argued that recent price corrections were an overreaction to the temporary issues the stock has been facing such as the talc-related bankruptcy filings and the Stelara patent expiration. Quote: T ...